338
Views
23
CrossRef citations to date
0
Altmetric
Reviews

Statins as potential treatment for cholesterol gallstones: an attempt to understand the underlying mechanism of actions

, , &
Pages 2673-2681 | Published online: 01 Nov 2011

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (10)

May Ahmed Shawki, Noha Salah Elsayed, Eman M. Mantawy & Riham S. Said. (2021) Promising drug repurposing approach targeted for cytokine storm implicated in SARS-CoV-2 complications. Immunopharmacology and Immunotoxicology 43:4, pages 395-409.
Read now
Nazik Elmalaika OS Husain & Mohamed H Ahmed. (2015) Managing dyslipidemia in HIV/AIDS patients: challenges and solutions. HIV/AIDS - Research and Palliative Care 7, pages 1-10.
Read now
Nazik Elmalaika Husain, Abdallah Tarig Hassan, Wadie M Elmadhoun & Mohamed H Ahmed. (2015) Evaluating the safety of Liptruzet (ezetimibe and atorvastatin): what are the potential benefits beyond low-density lipoprotein cholesterol-lowering effect?. Expert Opinion on Drug Safety 14:9, pages 1445-1455.
Read now
Yen-Chun Lee, Jin-Shang Wu, Yi-Ching Yang, Chin-Sung Chang, Feng-Hwa Lu & Chih-Jen Chang. (2014) Moderate to severe, but not mild, nonalcoholic fatty liver disease associated with increased risk of gallstone disease. Scandinavian Journal of Gastroenterology 49:8, pages 1001-1006.
Read now
Mohamed H. Ahmed & Asif Ali. (2014) Nonalcoholic fatty liver disease and cholesterol gallstones: Which comes first?. Scandinavian Journal of Gastroenterology 49:5, pages 521-527.
Read now
Mohamed H Ahmed, Ayman Al-Atta & Mahir A Hamad. (2012) The safety and effectiveness of statins as treatment for HIV-dyslipidemia: the evidence so far and the future challenges. Expert Opinion on Pharmacotherapy 13:13, pages 1901-1909.
Read now
Andrea Cariati & Elisa Piromalli. (2012) Limits and perspective of oral therapy with statins and aspirin for the prevention of symptomatic cholesterol gallstone disease. Expert Opinion on Pharmacotherapy 13:9, pages 1223-1227.
Read now
Mohamed H Ahmed, Vincent Connolly & Mahir A Hamad. (2012) Author's reply: statins and cholesterol gallstones: what we know, thought we knew and hope to gain. Expert Opinion on Pharmacotherapy 13:9, pages 1385-1386.
Read now
Andrea Cariati & Elisa Piromalli. (2012) Ultrastructural basis of the failure of oral dissolution therapy with bile salts and/or statin for cholesterol gallstones. Expert Opinion on Pharmacotherapy 13:9, pages 1387-1388.
Read now

Articles from other publishers (13)

立军 赵. (2023) Research Progress in the Prevention, Diagnosis and Treatment of Gallstones. Advances in Clinical Medicine 13:06, pages 9309-9319.
Crossref
Musaab Ahmed, Marium Ahmed, Dushyant Mital & Mohamed H. Ahmed. 2022. Cholesterol. Cholesterol 999 1020 .
Swarne E, M.S. Srikanth, Ayachit Shreyas, Sneha Desai, Seema Mehdi, H.V. Gangadharappa, Suman & K.L. Krishna. (2021) Recent advances, novel targets and treatments for cholelithiasis; a narrative review. European Journal of Pharmacology 908, pages 174376.
Crossref
Shou‑Feng Zhao, Ai‑Min Wang, Xin‑Juan Yu, Li‑Li Wang, Xiao‑Na Xu & Guang‑Jun Shi. (2019) Association between gallstone and cardio‑cerebrovascular disease: Systematic review and meta‑analysis. Experimental and Therapeutic Medicine.
Crossref
Agostino Di Ciaula & Piero Portincasa. (2018) Recent advances in understanding and managing cholesterol gallstones. F1000Research 7, pages 1529.
Crossref
Bryan Tungland. 2018. Human Microbiota in Health and Disease. Human Microbiota in Health and Disease 463 515 .
Eun‑Ji Lee, Min Kim, Ye‑Ryung Kim, Joo‑Won Park & Woo‑Jae Park. (2017) Proteasome inhibition protects against diet-induced gallstone formation through modulation of cholesterol and bile acid homeostasis. International Journal of Molecular Medicine.
Crossref
Yan ZhengMin XuYanping LiAdela HrubyEric B. RimmFrank B. HuJanine WirthChristine M. AlbertKathryn M. RexrodeJoAnn E. MansonLu Qi. (2016) Gallstones and Risk of Coronary Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 36:9, pages 1997-2003.
Crossref
Giovanni TargherChristopher D. Byrne. (2015) Gallstone Disease and Increased Risk of Ischemic Heart Disease. Arteriosclerosis, Thrombosis, and Vascular Biology 35:10, pages 2073-2075.
Crossref
He-Ping Kan, Wen-bin Guo, Yong-Fa Tan, Jie Zhou, Cun-dong Liu & Yu-Qi Huang. (2015) Statin use and risk of gallstone disease: A meta-analysis. Hepatology Research 45:9, pages 942-948.
Crossref
Yen-Chun Lee, Jin-Shang Wu, Yi-Ching Yang, Chin-Sung Chang, Feng-Hwa Lu & Chih-Jen Chang. (2014) Hepatitis B and Hepatitis C Associated with Risk of Gallstone Disease in Elderly Adults. Journal of the American Geriatrics Society 62:8, pages 1600-1602.
Crossref
Li Zhu. (2014) Prevalence of and risk factors for gallstones in Uighur and Han Chinese. World Journal of Gastroenterology 20:40, pages 14942.
Crossref
Jianwen Jiang, Zhigang Ren & Shusen Zheng. 2014. Infectious Microecology. Infectious Microecology 333 376 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.